Home / Brands / Generic Peptides / Generic Peptides Ipamorelin 2, 5 and 10 mg Research Vials
Generic Peptides Ipamorelin 2, 5 and 10 mg Research Vials
Generic Peptides Ipamorelin 2, 5 and 10 mg Research Vials
Generic Peptides Ipamorelin 2, 5 and 10 mg Research Vials
Generic Peptides

Generic Peptides Ipamorelin 2, 5 and 10 mg Research Vials

Injection · 2 mg · vial

Out of stock
$35.00

Generic Peptides Ipamorelin is a selective ghrelin receptor agonist pentapeptide supplied as a lyophilized research powder in three vial sizes: 2 mg, 5 mg and 10 mg.

GMP-manufactured, each batch is HPLC-verified with the Certificate of Analysis on file. Ipamorelin for sale with U.S. domestic and international shipping and dispatch within two business days after payment.

Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Generic Peptides Ipamorelin - 2 to 10 mg Research Vials

Generic Peptides Ipamorelin is a synthetic pentapeptide growth hormone secretagogue supplied as a lyophilized research powder in 2, 5 and 10 mg vials. It is a selective agonist at the ghrelin receptor, which is the property that separates it from the older and less selective GHRP-2 and GHRP-6 in this cluster.

  • Three vial sizes - 2, 5 and 10 mg
  • Selective ghrelin receptor agonist
  • Lyophilized powder
  • GMP-made, HPLC-verified, COA

Variant Comparison

One peptide, three strengths.

Variant Dosage Form and quantity Best use
Ipamorelin 2 mg 2 mg Vial Short
Ipamorelin 5 mg 5 mg Vial Standard
Ipamorelin 10 mg 10 mg Vial Extended

The 10 mg vial carries five times the material of the 2 mg vial, and the 5 and 10 mg sizes also have a U.S. domestic option. A GHRH analog such as CJC-1295 no DAC, the potent Hexarelin or the direct hormone Somatropin is the usual companion when selectivity has to be weighed against raw potency.

How Ipamorelin Works

Ipamorelin binds the ghrelin receptor on pituitary cells and triggers a growth hormone pulse. Its distinguishing feature comes from the 1998 work that introduced it as the first selective growth hormone secretagogue: at the doses studied it did not raise ACTH or cortisol above the levels seen after growth hormone-releasing hormone stimulation, so the release signal was cleaner than that of the hexapeptides. Published pharmacokinetics give an elimination half-life of about two hours, with the growth hormone peak reported at roughly forty minutes.

Reconstitution & Storage

The vial is dissolved with sterile or bacteriostatic water, which is not in the pack, added down the vial wall and swirled rather than shaken. Divide the milligrams on the vial by the millilitres added to read mg per mL. Keep the powder at 2-8 C or -20 C and the mixed solution at 2-8 C for four weeks.

Dosage & Administration

No human dose is stated here and the vial is not a medicine. Ipamorelin was investigated as an experimental secretagogue and holds no approved indication in any country, so nothing on this page is a treatment protocol or a dosing guide. Ipamorelin is named in WADA class S2.2.4 and is banned in sport at all times.

Supplied for laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use. Ipamorelin is supplied as a lyophilised powder and stays stable when the vial is kept cold and dry.

Specifications

Trade NameIpamorelin
Generic NameIpamorelin (NNC 26-0161)
ManufacturerGeneric Peptides
Dosage2 mg, 5 mg or 10 mg per vial
PackageLyophilized powder, one vial
Drug ClassPeptide; ghrelin receptor agonist
AdministrationSubcutaneous (research protocols)
StorageLyophilized 2-8 C or -20 C; mixed 2-8 C, 4 weeks
Prescription StatusResearch use only
VerificationBatch details confirmed with supplier
ShippingInternational about USD 35; USA option on 5 and 10 mg

Stacks

Selectivity Control Arm

Ipamorelin beside GHRP-6 as the non-selective comparator, so the cortisol and ACTH read-out can be attributed to selectivity rather than to dose.

Expected outcome: a clean separation of growth hormone release from the stress-hormone side of the class.

Two-Receptor Pulse Model

Ipamorelin with the GHRH analog CJC-1295 no DAC in the same arm, one input from the ghrelin receptor and one from the GHRH receptor.

Expected outcome: a growth hormone pulse model that combines two receptors in a single protocol.

Kinetics Comparison

Ipamorelin at about two hours against Somatropin as the direct hormone arm, where the release signal and the supplied hormone are read separately.

Expected outcome: a time course that shows how long each arm keeps its signal above baseline.

For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.

FAQ

Before you ask

Questions, answered

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue and a selective agonist at the ghrelin receptor, developed under the code NNC 26-0161. Its chain reads Aib-His-D-2-Nal-D-Phe-Lys-NH2, its formula is C38H49N9O5 and its mass is about 712 g/mol. It was described in 1998 as the first selective secretagogue because it raised growth hormone without raising ACTH or cortisol above GHRH-stimulated levels.

It binds the ghrelin receptor on pituitary cells and makes them release their own growth hormone in a pulse. The selectivity is the interesting part: in the original pharmacological work the compound did not release ACTH or cortisol at levels significantly different from those seen after growth hormone-releasing hormone stimulation, so the response stays closer to the growth axis than with the hexapeptide secretagogues.

Ipamorelin has no approved human use, so there is no label-based safety profile. Its cleaner selectivity means the ACTH and cortisol rise seen with GHRP-6 and hexarelin was not reproduced at the doses studied, but that is a pharmacological finding, not a safety guarantee. Injection-site reactions belong to the route, and any secretagogue can affect appetite. Treat it as an unstudied research material.

Add sterile or bacteriostatic water down the side of the vial and swirl, do not shake, then divide the milligrams on the vial by the millilitres added to read mg per mL. Keep the sealed powder at 2-8 C or -20 C and let it reach room temperature before opening. The mixed solution stays at 2-8 C and is used within about four weeks.

Yes. The WADA Prohibited List 2026 names ipamorelin in class S2.2.4, growth hormone releasing factors, in the growth hormone secretagogues group. Category S2 substances are prohibited at all times, in and out of competition. The same section names GHRP-6, examorelin (hexarelin), GHRP-2, sermorelin and tesamorelin, so the whole secretagogue cluster is covered.

Both act on the ghrelin receptor, but ipamorelin is a pentapeptide and GHRP-6 is a hexapeptide, and the shorter, more selective molecule does not carry the same hormonal spillover. GHRP-6 is the met-enkephalin-derived secretagogue associated with a strong appetite signal and a modest prolactin, ACTH and cortisol rise, while ipamorelin was reported to leave those stress hormones at GHRH-stimulated levels. Its half-life is about two hours.

All three vial sizes are listed on this page as research material with international and U.S. domestic checkout. International shipping runs about 35 dollars with a transit window of four to ten days, the domestic option is available on the 5 mg and 10 mg vials, and orders are handled within one to two business days. Stock and prices are shown live on the page.

No reviews yet

Be the first to share your experience with Generic Peptides Ipamorelin 2, 5 and 10 mg Research Vials

Log in to write a review

Complete the cycle

Stack it with

View all